Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates

Published: October 17, 2022

Doctor is examining heart's patient by echocardiogram for diagnosis disease or explain symptom.
  • Coronary heart disease is a cause of mortality and morbidity for kidney and liver transplant candidates and recipients. This is due to traditional and nontraditional risk factors and a somewhat unique pathophysiology present in patients without end-stage organ disease.
  • Optimizing strategies to disseminate and implement best practices for goal directed medical therapy in end-stage organ disease population should be prioritized to improve cardiovascular outcomes for transplant patients.
  • This scientific statement discusses evidence from the last decade related to coronary heart disease screening, and management for kidney and liver transplant candidates and emphasizes multi-disciplinary engagement, including a dedicated cardiologist.